Skip to main content

Table 4 Independent predictors of all-cause mortality

From: Combined value of left ventricular ejection fraction and the Model for End-Stage Liver Disease (MELD) score for predicting mortality in patients with acute coronary syndrome who were undergoing percutaneous coronary intervention

Variable

Univariate

Multivariate

HR

95% CI

p-value

HR

95% CI

p-value

Age (per 1 year)

1.042

1.029–1.056

< 0.001

1.023

1.008–1.038

0.002

Male

0.663

0.486–0.904

0.009

0.944

0.666–1.354

0.774

Diabetes mellitus

1.780

1.327–2.387

< 0.001

1.384

1.004–1.907

0.047

Hipertension

1.480

1.103–1.986

0.009

0.999

0.719–1.390

0.997

Stroke history

2.602

1.617–4.189

< 0.001

1.954

1.193–3.200

0.008

History of CAD

1.370

1.013–1.852

0.011

1.113

0.804–1.542

0.518

Major bleeding

1.898

0.970–3.713

0.068

0.812

0.395–1.669

0.571

Multi-vessel disease

1.872

1.392–2.518

< 0.001

1.197

0.866–1.654

0.276

Killip class ≥2

5.545

3.981–7.722

< 0.001

4.149

2.907–5.922

< 0.001

LVEF (per 1% change)

0.957

0.945–0.969

< 0.001

0.972

0.958–0.986

< 0.001

Hemoglobin (per 1 mg/dl)

0.805

0.748–0.866

< 0.001

0.887

0.816–0.965

0.005

WBC (per 103/L)

1.081

1.043–1.121

< 0.001

1.063

1.024–1.103

0.001

B-blocker use at follow-up

0.489

0.351–0.682

< 0.001

0.638

0.444–0.917

0.015

ACE/ARB use at follow-up

0.452

0.331–0.619

< 0.001

0.989

0.668–1.464

0.956

TVR

0.490

0.266–0.902

0.022

0.765

0.410–1.4128

0.401

MELDa score (per 1 point)

1.291

1.222–1.364

< 0.001

1.116

1.069–1.164

< 0.001

  1. HR hazard ratio, CI confidence interval, LVEF left ventricular ejection fraction, MELD model for end-stage liver disease, WBC white blood cell, HDL-C high-density lipoprotein cholesterol, ACE-I/ARB angiotensin-converting enzyme inhibitors/ angiotensin-reseptor blocker, TVR target vessel revascularization
  2. aConsidered as continous variable